查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1467848

2024-2032 年靜脈治療和靜脈通路市場（按類型、應用、最終用戶和地區）

Intravenous Therapy and Vein Access Market by Type, Application, End User, and Region 2024-2032
出版日期: | 出版商: IMARC | 英文 140 Pages | 商品交期: 2-3個工作天內

價格

2023 年，全球靜脈 (IV) 治療和靜脈通路市場規模達到 251 億美元。 展望未來， IMARC Group預計到 2032 年，市場規模將達到 382 億美元，2024 年複合年成長率 (CAGR) 為 4.64%。 2032.慢性病盛行率不斷上升、交通事故發生率不斷上升，以及消費者對靜脈注射療法益處的認知不斷提高，是推動市場發展的一些關鍵因素。

靜脈 (IV) 治療是一種醫療程序，涉及透過靜脈將液體、藥物和營養物質直接注射到血液中。此技術通常用於醫院、診所和其他醫療機構來治療各種病症和疾病。靜脈通路是進入靜脈進行靜脈注射治療的過程。醫療保健專業人員通常使用針刺穿皮膚並進入靜脈，由於靜脈細小或受損、脫水和肥胖等因素，這對某些患者來說可能具有挑戰性。靜脈注射療法有多種類型，包括用於脫水的鹽水溶液、用於感染的抗生素以及用於癌症治療的化學治療。除了治療疾病外，靜脈注射療法還可以用於預防措施，例如接種疫苗和維生素。

靜脈 (IV) 治療和靜脈通路市場趨勢：

癌症、糖尿病和自體免疫疾病等慢性病和生活方式疾病的盛行率不斷上升，需要長期用藥和監測，這主要推動了全球靜脈 (IV) 治療和靜脈通路市場的成長。除此之外，道路事故發生率的上升和創傷病例的激增也促進了市場的成長。此外，消費者對靜脈注射治療和靜脈通路益處的認知不斷提高，以及重症監護治療的興起，為市場帶來了有利可圖的成長機會。與此一致的是，對微創手術的偏好的轉變是另一個重要的成長誘導因素。除此之外，醫療保健行業的許多技術進步減少了所需的時間和精力，降低了感染風險並提高了手術的準確性，正在為市場創造積極的前景。同時，對創新療法、藥物和設備的研發（R&D）活動的​​大量投資也有助於市場擴張。此外，醫療保健支出的增加、醫院數量的增加、家庭醫療保健的廣泛採用以及老年人口的擴大正在加強市場的成長。

本報告回答的關鍵問題：

  • 迄今為止，全球靜脈 (IV) 治療和靜脈通路市場的表現如何，未來幾年將如何表現？
  • 全球靜脈 (IV) 治療和靜脈通路市場的促進因素、限制因素和機會是什麼？
  • 每個促進因素、限制因素和機會對全球靜脈 (IV) 治療和靜脈通路市場有何影響？
  • 主要區域市場有哪些？
  • 哪些國家代表了最具吸引力的靜脈 (IV) 治療和靜脈通路市場？
  • 依類型分類市場是怎麼樣的？
  • 靜脈 (IV) 治療和靜脈通路市場中哪種類型最具吸引力？
  • 基於應用的市場區隔是什麼？
  • 靜脈 (IV) 治療和靜脈通路市場中哪項應用最具吸引力？
  • 基於最終用戶的市場區隔是什麼？
  • 哪一個是靜脈 (IV) 治療和靜脈通路市場中最具吸引力的最終用戶？
  • 全球靜脈（IV）治療和靜脈通路市場的競爭結構如何？
  • 全球靜脈 (IV) 治療和靜脈通路市場的主要參與者/公司有哪些？

目錄

第1章：前言

第 2 章：範圍與方法

  • 研究目的
  • 利害關係人
  • 資料來源
    • 主要資源
    • 二手資料
  • 市場預測
    • 自下而上的方法
    • 自上而下的方法
  • 預測方法

第 3 章：執行摘要

第 4 章：簡介

  • 概述
  • 主要行業趨勢

第 5 章：全球靜脈 (IV) 治療與靜脈通路市場

  • 市場概況
  • 市場業績
  • COVID-19 的影響
  • 市場預測

第 6 章：市場區隔：按類型

  • 植入式連接埠
    • 市場走向
    • 市場預測
  • 靜脈導管
    • 市場走向
    • 市場預測
  • 皮下注射針
    • 市場走向
    • 市場預測
  • 點滴幫浦
    • 市場走向
    • 市場預測
  • 其他
    • 市場走向
    • 市場預測

第 7 章：市場區隔：按應用

  • 營養及緩衝液
    • 市場走向
    • 市場預測
  • 音量擴展器
    • 市場走向
    • 市場預測
  • 藥物管理
    • 市場走向
    • 市場預測
  • 血液製品
    • 市場走向
    • 市場預測

第 8 章：市場區隔：依最終用戶

  • 醫院
    • 市場走向
    • 市場預測
  • 門診手術中心
    • 市場走向
    • 市場預測
  • 診所
    • 市場走向
    • 市場預測

第 9 章：市場區隔：按地區

  • 北美洲
    • 美國
    • 加拿大
  • 亞太
    • 中國
    • 日本
    • 印度
    • 韓國
    • 澳洲
    • 印尼
    • 其他
  • 歐洲
    • 德國
    • 法國
    • 英國
    • 義大利
    • 西班牙
    • 俄羅斯
    • 其他
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 其他
  • 中東和非洲
    • 市場走向
    • 市場細分：按國家/地區
    • 市場預測

第 10 章：促進因素、限制與機會

  • 概述
  • 促進要素
  • 限制
  • 機會

第 11 章：價值鏈分析

第 12 章：波特五力分析

  • 概述
  • 買家的議價能力
  • 供應商的議價能力
  • 競爭程度
  • 新進入者的威脅
  • 替代品的威脅

第 13 章：價格分析

第14章：競爭格局

  • 市場結構
  • 關鍵參與者
  • 關鍵參與者簡介
    • AngioDynamics Inc.
    • B. Braun Melsungen AG
    • Baxter International Inc.
    • Becton Dickinson and Company
    • Cardinal Health Inc.
    • Fresenius SE & Co. KGaA
    • ICU Medical Inc.
    • Medtronic plc
    • Tekni-Plex Inc.
    • Teleflex Incorporated
    • Terumo Corporation
    • Vygon SAS
Product Code: SR112024A7524

The global intravenous (IV) therapy and vein access market size reached US$ 25.1 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 38.2 Billion by 2032, exhibiting a growth rate (CAGR) of 4.64% during 2024-2032. The growing prevalence of chronic diseases, the increasing incidences of road accidents, and the rising consumer awareness about the benefits of IV therapy represent some of the key factors driving the market.

Intravenous (IV) therapy is a medical procedure that involves administering fluids, medications, and nutrition directly into the bloodstream through a vein. This technique is commonly used in hospitals, clinics, and other healthcare facilities to treat various conditions and illnesses. Vein access is the process of entering a vein in order to administer IV therapy. A healthcare professional typically uses a needle to puncture the skin and access a vein, which can be challenging in some patients due to factors such as small or damaged veins, dehydration, and obesity. There are several types of IV therapy, including saline solutions for dehydration, antibiotics for infections, and chemotherapy for cancer treatment. In addition to treating medical conditions, IV therapy can also be used for preventative measures, such as receiving vaccinations and vitamins.

Intravenous (IV) Therapy and Vein Access Market Trends:

The increasing prevalence of chronic and lifestyle diseases, such as cancer, diabetes, and autoimmune diseases that require long-term medication and monitoring, is primarily driving the global intravenous (IV) therapy and vein access market growth. Besides this, the rising incidences of road accidents and the surging number of trauma cases are contributing to the market growth. Moreover, the escalating consumer awareness about the benefits of IV therapy and vein access and the rise in critical care therapies are presenting remunerative growth opportunities for the market. In line with this, the shifting preference for minimally invasive procedures is acting as another significant growth-inducing factor. In addition to this, numerous technological advancements in the healthcare industry to reduce the needed time and effort, lower the risk of infection, and improve the accuracy of the procedure are creating a positive outlook for the market. Concurrent with this, extensive investments in research and development (R&D) activities for innovating new therapies, drugs, and devices are aiding in market expansion. Furthermore, the increasing healthcare expenditure, rise in the number of hospitals, the widespread adoption of home healthcare, and the expanding geriatric population are strengthening the market growth.

Key Market Segmentation:

IMARC Group provides an analysis of the key trends in each segment of the global intravenous (IV) therapy and vein access market, along with forecasts at the global, regional, and country levels from 2024-2032. Our report has categorized the market based on type, application, and end user.

Type Insights:

Implantable Ports

Intravenous Catheters

Hypodermic Needles

Infusion Pumps

Others

The report has provided a detailed breakup and analysis of the intravenous (IV) therapy and vein access market based on the type. This includes implantable ports, intravenous catheters, hypodermic needles, infusion pumps, and others. According to the report, intravenous catheters represented the largest segment.

Application Insights:

Nutrition and Buffer Solution

Volume Expander

Medication Administration

Blood Based Products

A detailed breakup and analysis of the intravenous (IV) therapy and vein access market based on the application has also been provided in the report. This includes nutrition and buffer solution, volume expander, medication administration, and blood-based products. According to the report, medication administration accounted for the largest market share.

End User Insights:

Hospitals

Ambulatory Surgical Center

Clinics

The report has provided a detailed breakup and analysis of the intravenous (IV) therapy and vein access market based on the end user. This includes hospitals, ambulatory surgical centers, and clinics. According to the report, hospitals represented the largest segment.

Regional Insights:

North America

United States

Canada

Asia Pacific

China

Japan

India

South Korea

Australia

Indonesia

Others

Europe

Germany

France

United Kingdom

Italy

Spain

Russia

Others

Latin America

Brazil

Mexico

Others

Middle East and Africa

The report has also provided a comprehensive analysis of all the major regional markets, which include North America (the United States and Canada); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa. According to the report, North America was the largest market for intravenous (IV) therapy and vein access. Some of the factors driving the North America intravenous (IV) therapy and vein access market included the growing prevalence of chronic diseases, the increasing number of road accidents, and the expanding geriatric population.

Competitive Landscape:

The report has also provided a comprehensive analysis of the competitive landscape in the global intravenous (IV) therapy and vein access market. Detailed profiles of all major companies have also been provided. Some of the companies covered include AngioDynamics Inc., B. Braun Melsungen AG, Baxter International Inc., Becton Dickinson and Company, Cardinal Health Inc., Fresenius SE & Co. KGaA, ICU Medical Inc., Medtronic plc, Tekni-Plex Inc., Teleflex Incorporated, Terumo Corporation, Vygon SAS, etc. Kindly note that this only represents a partial list of companies, and the complete list has been provided in the report.

Key Questions Answered in This Report:

  • How has the global intravenous (IV) therapy and vein access market performed so far, and how will it perform in the coming years?
  • What are the drivers, restraints, and opportunities in the global intravenous (IV) therapy and vein access market?
  • What is the impact of each driver, restraint, and opportunity on the global intravenous (IV) therapy and vein access market?
  • What are the key regional markets?
  • Which countries represent the most attractive intravenous (IV) therapy and vein access market?
  • What is the breakup of the market based on the type?
  • Which is the most attractive type in the intravenous (IV) therapy and vein access market?
  • What is the breakup of the market based on the application?
  • Which is the most attractive application in the intravenous (IV) therapy and vein access market?
  • What is the breakup of the market based on the end user?
  • Which is the most attractive end user in the intravenous (IV) therapy and vein access market?
  • What is the competitive structure of the global intravenous (IV) therapy and vein access market?
  • Who are the key players/companies in the global intravenous (IV) therapy and vein access market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Intravenous (IV) Therapy and Vein Access Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Type

  • 6.1 Implantable Ports
    • 6.1.1 Market Trends
    • 6.1.2 Market Forecast
  • 6.2 Intravenous Catheters
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast
  • 6.3 Hypodermic Needles
    • 6.3.1 Market Trends
    • 6.3.2 Market Forecast
  • 6.4 Infusion Pumps
    • 6.4.1 Market Trends
    • 6.4.2 Market Forecast
  • 6.5 Others
    • 6.5.1 Market Trends
    • 6.5.2 Market Forecast

7 Market Breakup by Application

  • 7.1 Nutrition and Buffer Solution
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Volume Expander
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast
  • 7.3 Medication Administration
    • 7.3.1 Market Trends
    • 7.3.2 Market Forecast
  • 7.4 Blood Based Products
    • 7.4.1 Market Trends
    • 7.4.2 Market Forecast

8 Market Breakup by End User

  • 8.1 Hospitals
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Ambulatory Surgical Center
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast
  • 8.3 Clinics
    • 8.3.1 Market Trends
    • 8.3.2 Market Forecast

9 Market Breakup by Region

  • 9.1 North America
    • 9.1.1 United States
      • 9.1.1.1 Market Trends
      • 9.1.1.2 Market Forecast
    • 9.1.2 Canada
      • 9.1.2.1 Market Trends
      • 9.1.2.2 Market Forecast
  • 9.2 Asia-Pacific
    • 9.2.1 China
      • 9.2.1.1 Market Trends
      • 9.2.1.2 Market Forecast
    • 9.2.2 Japan
      • 9.2.2.1 Market Trends
      • 9.2.2.2 Market Forecast
    • 9.2.3 India
      • 9.2.3.1 Market Trends
      • 9.2.3.2 Market Forecast
    • 9.2.4 South Korea
      • 9.2.4.1 Market Trends
      • 9.2.4.2 Market Forecast
    • 9.2.5 Australia
      • 9.2.5.1 Market Trends
      • 9.2.5.2 Market Forecast
    • 9.2.6 Indonesia
      • 9.2.6.1 Market Trends
      • 9.2.6.2 Market Forecast
    • 9.2.7 Others
      • 9.2.7.1 Market Trends
      • 9.2.7.2 Market Forecast
  • 9.3 Europe
    • 9.3.1 Germany
      • 9.3.1.1 Market Trends
      • 9.3.1.2 Market Forecast
    • 9.3.2 France
      • 9.3.2.1 Market Trends
      • 9.3.2.2 Market Forecast
    • 9.3.3 United Kingdom
      • 9.3.3.1 Market Trends
      • 9.3.3.2 Market Forecast
    • 9.3.4 Italy
      • 9.3.4.1 Market Trends
      • 9.3.4.2 Market Forecast
    • 9.3.5 Spain
      • 9.3.5.1 Market Trends
      • 9.3.5.2 Market Forecast
    • 9.3.6 Russia
      • 9.3.6.1 Market Trends
      • 9.3.6.2 Market Forecast
    • 9.3.7 Others
      • 9.3.7.1 Market Trends
      • 9.3.7.2 Market Forecast
  • 9.4 Latin America
    • 9.4.1 Brazil
      • 9.4.1.1 Market Trends
      • 9.4.1.2 Market Forecast
    • 9.4.2 Mexico
      • 9.4.2.1 Market Trends
      • 9.4.2.2 Market Forecast
    • 9.4.3 Others
      • 9.4.3.1 Market Trends
      • 9.4.3.2 Market Forecast
  • 9.5 Middle East and Africa
    • 9.5.1 Market Trends
    • 9.5.2 Market Breakup by Country
    • 9.5.3 Market Forecast

10 Drivers, Restraints, and Opportunities

  • 10.1 Overview
  • 10.2 Drivers
  • 10.3 Restraints
  • 10.4 Opportunities

11 Value Chain Analysis

12 Porters Five Forces Analysis

  • 12.1 Overview
  • 12.2 Bargaining Power of Buyers
  • 12.3 Bargaining Power of Suppliers
  • 12.4 Degree of Competition
  • 12.5 Threat of New Entrants
  • 12.6 Threat of Substitutes

13 Price Analysis

14 Competitive Landscape

  • 14.1 Market Structure
  • 14.2 Key Players
  • 14.3 Profiles of Key Players
    • 14.3.1 AngioDynamics Inc.
      • 14.3.1.1 Company Overview
      • 14.3.1.2 Product Portfolio
      • 14.3.1.3 Financials
      • 14.3.1.4 SWOT Analysis
    • 14.3.2 B. Braun Melsungen AG
      • 14.3.2.1 Company Overview
      • 14.3.2.2 Product Portfolio
    • 14.3.3 Baxter International Inc.
      • 14.3.3.1 Company Overview
      • 14.3.3.2 Product Portfolio
      • 14.3.3.3 Financials
      • 14.3.3.4 SWOT Analysis
    • 14.3.4 Becton Dickinson and Company
      • 14.3.4.1 Company Overview
      • 14.3.4.2 Product Portfolio
      • 14.3.4.3 Financials
      • 14.3.4.4 SWOT Analysis
    • 14.3.5 Cardinal Health Inc.
      • 14.3.5.1 Company Overview
      • 14.3.5.2 Product Portfolio
      • 14.3.5.3 Financials
      • 14.3.5.4 SWOT Analysis
    • 14.3.6 Fresenius SE & Co. KGaA
      • 14.3.6.1 Company Overview
      • 14.3.6.2 Product Portfolio
      • 14.3.6.3 Financials
      • 14.3.6.4 SWOT Analysis
    • 14.3.7 ICU Medical Inc.
      • 14.3.7.1 Company Overview
      • 14.3.7.2 Product Portfolio
      • 14.3.7.3 Financials
      • 14.3.7.4 SWOT Analysis
    • 14.3.8 Medtronic plc
      • 14.3.8.1 Company Overview
      • 14.3.8.2 Product Portfolio
      • 14.3.8.3 Financials
      • 14.3.8.4 SWOT Analysis
    • 14.3.9 Tekni-Plex Inc.
      • 14.3.9.1 Company Overview
      • 14.3.9.2 Product Portfolio
    • 14.3.10 Teleflex Incorporated
      • 14.3.10.1 Company Overview
      • 14.3.10.2 Product Portfolio
      • 14.3.10.3 Financials
      • 14.3.10.4 SWOT Analysis
    • 14.3.11 Terumo Corporation
      • 14.3.11.1 Company Overview
      • 14.3.11.2 Product Portfolio
      • 14.3.11.3 Financials
      • 14.3.11.4 SWOT Analysis
    • 14.3.12 Vygon SAS
      • 14.3.12.1 Company Overview
      • 14.3.12.2 Product Portfolio

Kindly note that this only represents a partial list of companies, and the complete list has been provided in the report.

List of Figures

  • Figure 1: Global: Intravenous Therapy and Vein Access Market: Major Drivers and Challenges
  • Figure 2: Global: Intravenous Therapy and Vein Access Market: Sales Value (in Billion US$), 2018-2023
  • Figure 3: Global: Intravenous Therapy and Vein Access Market Forecast: Sales Value (in Billion US$), 2024-2032
  • Figure 4: Global: Intravenous Therapy and Vein Access Market: Breakup by Type (in %), 2023
  • Figure 5: Global: Intravenous Therapy and Vein Access Market: Breakup by Application (in %), 2023
  • Figure 6: Global: Intravenous Therapy and Vein Access Market: Breakup by End User (in %), 2023
  • Figure 7: Global: Intravenous Therapy and Vein Access Market: Breakup by Region (in %), 2023
  • Figure 8: Global: Intravenous Therapy and Vein Access (Implantable Ports) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 9: Global: Intravenous Therapy and Vein Access (Implantable Ports) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 10: Global: Intravenous Therapy and Vein Access (Intravenous Catheters) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 11: Global: Intravenous Therapy and Vein Access (Intravenous Catheters) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 12: Global: Intravenous Therapy and Vein Access (Hypodermic Needles) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 13: Global: Intravenous Therapy and Vein Access (Hypodermic Needles) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 14: Global: Intravenous Therapy and Vein Access (Infusion Pumps) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 15: Global: Intravenous Therapy and Vein Access (Infusion Pumps) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 16: Global: Intravenous Therapy and Vein Access (Other Types) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 17: Global: Intravenous Therapy and Vein Access (Other Types) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 18: Global: Intravenous Therapy and Vein Access (Nutrition and Buffer Solution) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 19: Global: Intravenous Therapy and Vein Access (Nutrition and Buffer Solution) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 20: Global: Intravenous Therapy and Vein Access (Volume Expander) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 21: Global: Intravenous Therapy and Vein Access (Volume Expander) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 22: Global: Intravenous Therapy and Vein Access (Medication Administration) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 23: Global: Intravenous Therapy and Vein Access (Medication Administration) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 24: Global: Intravenous Therapy and Vein Access (Blood Based Products) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 25: Global: Intravenous Therapy and Vein Access (Blood Based Products) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 26: Global: Intravenous Therapy and Vein Access (Hospitals) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 27: Global: Intravenous Therapy and Vein Access (Hospitals) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 28: Global: Intravenous Therapy and Vein Access (Ambulatory Surgical Center) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 29: Global: Intravenous Therapy and Vein Access (Ambulatory Surgical Center) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 30: Global: Intravenous Therapy and Vein Access (Clinics) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 31: Global: Intravenous Therapy and Vein Access (Clinics) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 32: North America: Intravenous Therapy and Vein Access Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 33: North America: Intravenous Therapy and Vein Access Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 34: United States: Intravenous Therapy and Vein Access Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 35: United States: Intravenous Therapy and Vein Access Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 36: Canada: Intravenous Therapy and Vein Access Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 37: Canada: Intravenous Therapy and Vein Access Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 38: Asia-Pacific: Intravenous Therapy and Vein Access Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 39: Asia-Pacific: Intravenous Therapy and Vein Access Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 40: China: Intravenous Therapy and Vein Access Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 41: China: Intravenous Therapy and Vein Access Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 42: Japan: Intravenous Therapy and Vein Access Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 43: Japan: Intravenous Therapy and Vein Access Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 44: India: Intravenous Therapy and Vein Access Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 45: India: Intravenous Therapy and Vein Access Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 46: South Korea: Intravenous Therapy and Vein Access Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 47: South Korea: Intravenous Therapy and Vein Access Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 48: Australia: Intravenous Therapy and Vein Access Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 49: Australia: Intravenous Therapy and Vein Access Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 50: Indonesia: Intravenous Therapy and Vein Access Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 51: Indonesia: Intravenous Therapy and Vein Access Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 52: Others: Intravenous Therapy and Vein Access Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 53: Others: Intravenous Therapy and Vein Access Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 54: Europe: Intravenous Therapy and Vein Access Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 55: Europe: Intravenous Therapy and Vein Access Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 56: Germany: Intravenous Therapy and Vein Access Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 57: Germany: Intravenous Therapy and Vein Access Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 58: France: Intravenous Therapy and Vein Access Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 59: France: Intravenous Therapy and Vein Access Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 60: United Kingdom: Intravenous Therapy and Vein Access Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 61: United Kingdom: Intravenous Therapy and Vein Access Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 62: Italy: Intravenous Therapy and Vein Access Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 63: Italy: Intravenous Therapy and Vein Access Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 64: Spain: Intravenous Therapy and Vein Access Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 65: Spain: Intravenous Therapy and Vein Access Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 66: Russia: Intravenous Therapy and Vein Access Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 67: Russia: Intravenous Therapy and Vein Access Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 68: Others: Intravenous Therapy and Vein Access Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 69: Others: Intravenous Therapy and Vein Access Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 70: Latin America: Intravenous Therapy and Vein Access Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 71: Latin America: Intravenous Therapy and Vein Access Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 72: Brazil: Intravenous Therapy and Vein Access Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 73: Brazil: Intravenous Therapy and Vein Access Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 74: Mexico: Intravenous Therapy and Vein Access Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 75: Mexico: Intravenous Therapy and Vein Access Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 76: Others: Intravenous Therapy and Vein Access Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 77: Others: Intravenous Therapy and Vein Access Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 78: Middle East and Africa: Intravenous Therapy and Vein Access Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 79: Middle East and Africa: Intravenous Therapy and Vein Access Market: Breakup by Country (in %), 2023
  • Figure 80: Middle East and Africa: Intravenous Therapy and Vein Access Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 81: Global: Intravenous Therapy and Vein Access Industry: Drivers, Restraints, and Opportunities
  • Figure 82: Global: Intravenous Therapy and Vein Access Industry: Value Chain Analysis
  • Figure 83: Global: Intravenous Therapy and Vein Access Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Intravenous Therapy and Vein Access Market: Key Industry Highlights, 2023 & 2032
  • Table 2: Global: Intravenous Therapy and Vein Access Market Forecast: Breakup by Type (in Million US$), 2024-2032
  • Table 3: Global: Intravenous Therapy and Vein Access Market Forecast: Breakup by Application (in Million US$), 2024-2032
  • Table 4: Global: Intravenous Therapy and Vein Access Market Forecast: Breakup by End User (in Million US$), 2024-2032
  • Table 5: Global: Intravenous Therapy and Vein Access Market Forecast: Breakup by Region (in Million US$), 2024-2032
  • Table 6: Global: Intravenous Therapy and Vein Access Market: Competitive Structure
  • Table 7: Global: Intravenous Therapy and Vein Access Market: Key Players